Key result
Renal tubular epithelial cell IL-18 deficiency protects against DOCA-salt-induced hypertension, renal inflammation, and fibrosis.
Answers are grounded in this paper and cite their sources.
IL-18 (interleukin-18) is elevated in hypertensive patients, but its contribution to high blood pressure and end-organ damage is unknown. We examined the role of IL-18 in the development of renal inflammation and injury in a mouse model of low-renin hypertension. Hypertension was induced in male C57BL6/J (WT) and IL-18−/− mice by uninephrectomy, deoxycorticosterone acetate (2.4 mg/d, s.c.) and 0.9% drinking saline (1K/DOCA/salt). Normotensive controls received uninephrectomy and placebo (1K/placebo). Blood pressure was measured via tail cuff or radiotelemetry. After 21 days, kidneys were harvested for (immuno)histochemical, quantitative-PCR and flow cytometric analyses of fibrosis, inflammation, and immune cell infiltration. 1K/DOCA/salt-treated WT mice developed hypertension, renal fibrosis, upregulation of proinflammatory genes, and accumulation of CD3+ T cells in the kidneys. They also displayed increased expression of IL-18 on tubular epithelial cells. IL-18−/− mice were profoundly protected from hypertension, renal fibrosis, and inflammation. Bone marrow transplantation between WT and IL-18−/− mice revealed that IL-18-deficiency in non-bone marrow-derived cells alone afforded equivalent protection against hypertension and renal injury as global IL-18 deficiency. IL-18 receptor subunits—interleukin-18 receptor 1 and IL-18R accessory protein—were upregulated in kidneys of 1K/DOCA/salt-treated WT mice and localized to T cells and tubular epithelial cells. T cells from kidneys of 1K/DOCA/salt-treated mice produced interferon-γ upon ex vivo stimulation with IL-18, whereas those from 1K/placebo mice did not. In conclusion, IL-18 production by tubular epithelial cells contributes to elevated blood pressure, renal inflammation, and fibrosis in 1K/DOCA/salt-treated mice, highlighting it as a promising therapeutic target for hypertension and kidney disease.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2021) studied Deoxycorticosterone/salt-induced low-renin hypertension and renal injury (mouse model). IL-18 deficiency (and bone marrow transplantation) in 1K/DOCA/salt-induced hypertension vs. Wild-type 1K/DOCA/salt mice and normotensive 1K/placebo controls was evaluated on Blood pressure, renal fibrosis, renal inflammation, and immune cell infiltration. IL-18 deficiency in non-bone marrow-derived renal tubular epithelial cells protected mice against 21-day 1K/DOCA/salt-induced hypertension, renal inflammation, and fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: